0
Editorial |

Healing Words: Title and subTitle BreakEmotional Expression and Disease Outcome

David Spiegel, MD
JAMA. 1999;281(14):1328-1329. doi:10.1001/jama.281.14.1328
Text Size: A A A
Published online

We have been closet Cartesians in modern medicine, treating the mind as though it were reactive to but otherwise disconnected from disease in the body. Although medical science has productively focused on the pathophysiology of disease, such as tumor biology, coronary artery disease, and immunology, it has done so at the expense of studying the body's psychophysiological reactions to these disease processes. These reactions are mediated by brain and body mechanisms, including the endocrine, neuroimmune, and autonomic nervous systems. While a large portion of the variance in any disease outcome is accounted for by the specific local pathophysiology of that disease, some variability must also be explained by host resistance factors, which include the manner of response to the stress of the illness. For example, in a series of classic experiments in animals, Riley1 2 showed that crowding accelerated the rate of tumor growth and mortality. In a recent authoritative review of human stress literature, McEwen3 documented the adverse health effects of cumulative stressors and the body's failure to adapt the stress response to them. Activation of the hypothalamic-pituitary-adrenal axis (HPA) is an adaptive response to acute stress, but over time, in response to cumulative stress, the system's signal-to-noise ratio can be degraded, so that it is partially "on" all the time, leading to adverse physiological consequences, including abnormalities of glucose metabolism,4 hippocampal damage,5 and depression.6 7

Abnormalities of hypothalamic function, including glucocorticoid receptor hypersensitivity, have also been found to be associated with posttraumatic stress disorder.8 9 Thus, adverse emotional events, ranging from traumatic stressors to cumulative minor ones, are associated with HPA dysregulation. Glucocorticoids are potently immunosuppressive, so the effects of acute and chronic stress and hypercortisolemia may include functional immunosuppression as well, as has been shown extensively in animals,10 13 and for which there is a growing body of evidence in humans.14 15

On the other hand, the social environment can have a buffering effect on stress. The same stressor that when given to an animal who is alone increases plasma cortisol levels by 50% does not increase it at all when the animal is surrounded by familiar companions.16 Being socially imbedded is associated with less autonomic arousal than social isolation.17 Indeed, social connection has profound consequences for health. Being well integrated socially reduces all-cause age-adjusted mortality by a factor of 2-fold, about as much as having low vs high serum cholesterol levels or being a nonsmoker.18 Furthermore, the nature of one's position in the social hierarchy has health consequences, including relatively higher status within the same social class.19 People are statistically more likely to die after rather than before their birthdays and important holidays.20

Thus, the presence of adverse emotional events such as traumatic stressors seems to have negative potential health consequences, while good social relations seem to be associated with positive health outcomes. Results from a recent randomized trial of patients who after experiencing myocardial infarction had participated in a program that included group support, stress management, and a vegetarian diet showed a long-term reversal of coronary artery occlusion.21 22 Similarly, 323 25 of 626 28 published randomized trials have provided evidence that psychosocial support is associated with longer survival for patients with breast cancer, malignant melanoma, and lymphoma. Patients with psoriasis exposed to mindfulness-meditation training tapes during treatment showed more rapid healing of lesions than those who were not exposed.29 One component of the effective interventions is dealing directly with emotional distress associated with fears regarding disease progression.30

There is evidence that resilience to stress, including disease-related distress, is associated with how people handle their emotions.31 Indeed, finding meaning in the midst of a distressing situation has been linked with a positive psychological state.32 Adaptating to a situation well does not require that a person maintain an upbeat or a rigidly positive attitude. Rather, it involves dealing directly with negative affect. Positive and negative emotions are not merely opposite sides of 1 dimension.33 Rather, the suppression of negative emotion tends to reduce a person's ability to experience any emotion, positive or negative. There is evidence that patients with breast cancer who express negative emotion, including anger and uncooperativeness,34 or patients who express realistic optimism, often termed having the fighting spirit,35 actually live longer than those who don't.

In this issue of THE JOURNAL, Smyth and colleagues36 demonstrate that merely writing about past stressful life experiences results in symptom reduction among patients with asthma or rheumatoid arthritis. Patients wrote about the "most stressful experience in their entire life" for just 20 minutes over 3 consecutive days, while controls wrote about their daily schedule, following a method developed by Pennebaker et al,37 who showed that such an experience improves immune function.38 Patients with asthma randomized to spend this limited amount of time writing about distressing experiences showed increased forced expiratory volume at 4-month follow-up, and similarly, patients with rheumatoid arthritis had significant reduction in disease-related symptoms, moving from a moderate to a mild range. This study adds important data to the growing evidence that even limited interventions designed to improve management of stress may have lasting somatic effects. It is quite plausible that the interaction between disease and the stress it causes can set up an interaction that reinforces the illness, through autonomic hyperactivity, increased HPA activity or dysregulation, and effects on immune function.

Were the authors to have provided similar outcome evidence about a new drug, it likely would be in widespread use within a short time. Why? We would think we understood the "mechanism" (whether we did or not) and there would be a mediating industry to promote its use. Manufacturers of paper and pencils are not likely to push journaling as a treatment addition for the management of asthma and rheumatoid arthritis. But the authors have provided evidence that medical treatment is more effective when standard pharmacological intervention is combined with the management of emotional distress. Ventilation of negative emotion, even just to an unknown reader, seems to have helped these patients acknowledge, bear, and put into perspective their distress. As has been noted before,39 it is not so much the nature of the "treatment on offer that determines whether the medicine is orthodox or alternative but the quality of evidence adduced in its favour."39 In this and a growing number of studies, it is not simply mind over matter, but it is clear that mind matters.

REFERENCES

Riley V. Mouse mammary tumors: alteration of incidence as apparent function of stress.  Science.1975;189:465-467.
Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia.  Science.1981;212:1100-1109.
McEwen BS. Protective and damaging effects of stress mediators.  N Engl J Med.1998;338:171-179.
Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids.  Endocrinology.1985;117:662-666.
Sapolsky R, Krey L, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implication for aging.  J Neurosci.1985;5:1222-1227.
Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis.  Psychiatr Clin North Am.1998;21:293-307.
Posener JA, Schildkraut JJ, Samson JA, Schatzberg AF. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects.  Psychoneuroendocrinology.1996;21:33-38.
Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.  Am J Psychiatry.1993;150:83-86.
Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis.  Biol Psychiatry.1996;40:79-88.
Sheridan JF, Dobbs C, Brown D, Zwilling B. Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection.  Clin Microbiol Rev.1994;7:200-212.
Sheridan JF, Dobbs C, Jung J.  et al.  Stress-induced neuroendocrine modulation of viral pathogenesis and immunity.  Ann N Y Acad Sci.1998;840:803-808.
Padgett DA, Loria RM, Sheridan JF. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol.  J Neuroimmunol.1997;78:203-211.
Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease.  Ann Intern Med.1992;117:854-866.
Glaser R, Kiecolt-Glaser JK, Malarkey WB, Sheridan JF. The influence of psychological stress on the immune response to vaccines.  Ann N Y Acad Sci.1998;840:649-655.
Kiecolt-Glaser JK, Glaser R, Cacioppo JT, Malarkey WB. Marital stress: immunologic, neuroendocrine, and autonomic correlates.  Ann N Y Acad Sci.1998;840:656-663.
Levine S, Lyons DM, Schatzberg AF. Psychobiological consequences of social relationships.  Ann N Y Acad Sci.1997;807:210-218.
Cacioppo JT. Social neuroscience: autonomic, neuroendocrine, and immune responses to stress.  Psychophysiology.1994;31:113-128.
House JS, Landis KR, Umberson D. Social relationships and health.  Science.1988;241:540-545.
Marmot MG, Fuhrer R, Ettner SL, Marks NF, Bumpass LL, Ryff CD. Contribution of psychosocial factors to socioeconomic differences in health.  Milbank Q.1998;76:403-448.
Phillips DP, Ruth TE, Wagner LM. Psychology and survival.  Lancet.1993;342:1142-1145.
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA. Can lifestyle changes reverse coronary heart disease? the Lifestyle Heart Trial.  Lancet.1990;336:129-133.
Ornish D, Scherwitz LW, Billings JH.  et al.  Intensive lifestyle changes for reversal of coronary heart disease.  JAMA.1998;280:2001-2007.
Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer.  Lancet.1989;2:888-891.
Fawzy FI, Fawzy NW, Hyun CS.  et al.  Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.  Arch Gen Psychiatry.1993;50:681-689.
Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies.  J Clin Oncol.1990;8:356-364.
Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer.  Cancer.1982;49:1048-1055.
Ilnyckyj A, Farber J, Cheang M, Weinerman B. A randomized controlled trial of psychotherapeutic intervention in cancer patients.  Ann Coll Physicians Surg Can.1994;27:93-96.
Cunningham AJ, Edmonds CVI, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer.  Psycho-oncology.1998;7:508-517.
Kabat-Zinn J, Wheeler E, Light T.  et al.  Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (uvb) and photochemotherapy (puva).  Psychosom Med.1998;60:625-632.
Spiegel D. Psychosocial intervention in cancer.  J Natl Cancer Inst.1993;85:1198-1205.
Davidson RJ, Sutton SK. Affective neuroscience: the emergence of a discipline.  Curr Opin Neurobiol.1995;5:217-224.
Folkman S. Positive psychological states and coping with severe stress.  Soc Sci Med.1997;45:1207-1221.
Lane RD, Reiman EM, Bradley MM.  et al.  Neuroanatomical correlates of pleasant and unpleasant emotion.  Neuropsychologia.1997;35:1437-1444.
Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer.  JAMA.1979;242:1504-1508.
Greer S. Psychological response to cancer and survival.  Psychol Med.1991;21:43-49.
Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial.  JAMA.1999;281:1304-1309.
Pennebaker JW, Colder M, Sharp LK. Accelerating the coping process.  J Pers Soc Psychol.1990;58:528-537.
Pennebaker JW, Kiecolt-Glaser J, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy.  J Consult Clin Psychol.1988;56:239-245.
Not Available.  Psychosocial intervention and the natural history of cancer [editorial].  Lancet.1989;2:901.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Riley V. Mouse mammary tumors: alteration of incidence as apparent function of stress.  Science.1975;189:465-467.
Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia.  Science.1981;212:1100-1109.
McEwen BS. Protective and damaging effects of stress mediators.  N Engl J Med.1998;338:171-179.
Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids.  Endocrinology.1985;117:662-666.
Sapolsky R, Krey L, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implication for aging.  J Neurosci.1985;5:1222-1227.
Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis.  Psychiatr Clin North Am.1998;21:293-307.
Posener JA, Schildkraut JJ, Samson JA, Schatzberg AF. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects.  Psychoneuroendocrinology.1996;21:33-38.
Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.  Am J Psychiatry.1993;150:83-86.
Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis.  Biol Psychiatry.1996;40:79-88.
Sheridan JF, Dobbs C, Brown D, Zwilling B. Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection.  Clin Microbiol Rev.1994;7:200-212.
Sheridan JF, Dobbs C, Jung J.  et al.  Stress-induced neuroendocrine modulation of viral pathogenesis and immunity.  Ann N Y Acad Sci.1998;840:803-808.
Padgett DA, Loria RM, Sheridan JF. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol.  J Neuroimmunol.1997;78:203-211.
Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease.  Ann Intern Med.1992;117:854-866.
Glaser R, Kiecolt-Glaser JK, Malarkey WB, Sheridan JF. The influence of psychological stress on the immune response to vaccines.  Ann N Y Acad Sci.1998;840:649-655.
Kiecolt-Glaser JK, Glaser R, Cacioppo JT, Malarkey WB. Marital stress: immunologic, neuroendocrine, and autonomic correlates.  Ann N Y Acad Sci.1998;840:656-663.
Levine S, Lyons DM, Schatzberg AF. Psychobiological consequences of social relationships.  Ann N Y Acad Sci.1997;807:210-218.
Cacioppo JT. Social neuroscience: autonomic, neuroendocrine, and immune responses to stress.  Psychophysiology.1994;31:113-128.
House JS, Landis KR, Umberson D. Social relationships and health.  Science.1988;241:540-545.
Marmot MG, Fuhrer R, Ettner SL, Marks NF, Bumpass LL, Ryff CD. Contribution of psychosocial factors to socioeconomic differences in health.  Milbank Q.1998;76:403-448.
Phillips DP, Ruth TE, Wagner LM. Psychology and survival.  Lancet.1993;342:1142-1145.
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA. Can lifestyle changes reverse coronary heart disease? the Lifestyle Heart Trial.  Lancet.1990;336:129-133.
Ornish D, Scherwitz LW, Billings JH.  et al.  Intensive lifestyle changes for reversal of coronary heart disease.  JAMA.1998;280:2001-2007.
Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer.  Lancet.1989;2:888-891.
Fawzy FI, Fawzy NW, Hyun CS.  et al.  Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.  Arch Gen Psychiatry.1993;50:681-689.
Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies.  J Clin Oncol.1990;8:356-364.
Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer.  Cancer.1982;49:1048-1055.
Ilnyckyj A, Farber J, Cheang M, Weinerman B. A randomized controlled trial of psychotherapeutic intervention in cancer patients.  Ann Coll Physicians Surg Can.1994;27:93-96.
Cunningham AJ, Edmonds CVI, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer.  Psycho-oncology.1998;7:508-517.
Kabat-Zinn J, Wheeler E, Light T.  et al.  Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (uvb) and photochemotherapy (puva).  Psychosom Med.1998;60:625-632.
Spiegel D. Psychosocial intervention in cancer.  J Natl Cancer Inst.1993;85:1198-1205.
Davidson RJ, Sutton SK. Affective neuroscience: the emergence of a discipline.  Curr Opin Neurobiol.1995;5:217-224.
Folkman S. Positive psychological states and coping with severe stress.  Soc Sci Med.1997;45:1207-1221.
Lane RD, Reiman EM, Bradley MM.  et al.  Neuroanatomical correlates of pleasant and unpleasant emotion.  Neuropsychologia.1997;35:1437-1444.
Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer.  JAMA.1979;242:1504-1508.
Greer S. Psychological response to cancer and survival.  Psychol Med.1991;21:43-49.
Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial.  JAMA.1999;281:1304-1309.
Pennebaker JW, Colder M, Sharp LK. Accelerating the coping process.  J Pers Soc Psychol.1990;58:528-537.
Pennebaker JW, Kiecolt-Glaser J, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy.  J Consult Clin Psychol.1988;56:239-245.
Not Available.  Psychosocial intervention and the natural history of cancer [editorial].  Lancet.1989;2:901.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Recognizing Emotions From an Ensemble of Features.
IEEE Trans Syst Man Cybern B Cybern. Published online May 3, 2012.